$51.99 (0%)

Volume: 0

Closed: Jan 27, 2023

Hollow Logo Score: 0.000
ChemoCentryx Stock
$51.99 (0%)

Volume: 0

Closed: Jan 27, 2023

Score Hollow Logo 0.000
NASDAQ:CCXI

ChemoCentryx Stock Predictions

Currently predicting for Mon, 30 Jan 2023

CCXI Predictions History

4 months ago
chriscasazza1 predicted that CCXI for 2022-09-26 is going

Rank:

1 year ago
JS predicted that CCXI for 2021-10-12 is going $38.16 (6.00%)

1 year ago
novbarber predicted that CCXI for 2021-10-12 is going

Rank:

1 year ago
JS predicted that CCXI for 2021-05-10 is going $14.68 (40.34%)

1 year ago
Александр1 predicted that CCXI for 2021-05-10 is going $33.49 (220.17%)

Rank:

2 years ago
EmmanuelNzekwe143383 predicted that CCXI for 2020-03-04 is going

Rank:

2 years ago
Eitan Yehoshua predicted that CCXI for 2020-02-06 is going

Rank:

2 years ago
JS predicted that CCXI for 2020-02-05 is going $45.82 (-2.84%)

2 years ago
2poJeff predicted that CCXI for 2020-02-05 is going $44.98 (-0.62%)

2 years ago
Faisal.Azizullah.17207 predicted that CCXI for 2020-02-05 is going $44.89 (-0.82%)

Rank:

Hot Stocks To Watch:

About ChemoCentryx

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT